Perioperative diltiazem therapy was not associated with improved perioperative and long-term outcomes in patients undergoing on-pump coronary artery bypass grafting

BACKGROUND: Diltiazem has been used during the perioperative period in patients undergoing coronary artery bypass grafting (CABG) to prevent arterial graft spasm. However, its long-term outcome effects remain unclear. METHODS: Patient records obtained from the Society of Thoracic Surgeons and the Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaopeng, Hu, Yirui, Friscia, Michael E., Wu, Xianren, Zhang, Li, Casale, Alfred S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430801/
https://www.ncbi.nlm.nih.gov/pubmed/37588585
http://dx.doi.org/10.1016/j.bjao.2022.100025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430801/
https://www.ncbi.nlm.nih.gov/pubmed/37588585
http://dx.doi.org/10.1016/j.bjao.2022.100025

Ejemplares similares